Knee Osteoarthritis and Corticosteroid Injections (Intra‑articular)

Knee osteoarthritis (KOA) produces pain and disability through a combination of cartilage degeneration, subchondral bone remodeling, and intermittent synovial inflammation. The inflammatory component is clinically important: effusions, warmth, and morning stiffness reflect synovitis that heightens nociception and limits motion. Intra‑articular corticosteroid injections capitalize on this target by delivering potent anti‑inflammatories directly to the joint, suppressing phospholipase A2 and pro‑inflammatory cytokines within the synovium. Clinically, this translates to relatively rapid symptom improvement—often within days—with peak benefit in the first 1–2 weeks and a typical duration of relief around 2–6 weeks. Meta‑analyses consistently confirm a small to moderate short‑term advantage over saline injections. However, benefits usually fade by 6–12 weeks, and the therapy does not modify the disease course. Comparative evidence positions corticosteroids as faster‑acting than hyaluronic acid (HA) but generally shorter in duration; platelet‑rich plasma (PRP) frequently outperforms both in longevity of benefit, though PRP protocols vary and access can be limited. A landmark randomized trial found that administering triamcinolone every three months over two years produced greater cartilage volume loss than saline without superior pain control. This has led guidelines to emphasize prudent use: reserve injections for flares or discrete functional setbacks, and avoid frequent, long‑term scheduling. Safety is favorable overall. Short‑term flares, facial flushing, and transient hyperglycemia (notably in diabetes) are the most common effects; septic arthritis is rare but serious. Systemic exposure is minimal yet can briefly affect mood, sleep, or blood pressure. Patient selection focuses on symptomatic KOA with evidence of inflammation (e.g., effusion) where short‑term relief can enable rehabilitation or activity goals. Absolute contraindications include active joint or overlying skin infection, bacteremia, and true allergy to components; relative cautions include poorly controlled diabetes, recent or upcoming joint replacement (especially within ~3 months), and bleeding risks. Ultrasound guidance may improve accuracy. Importantly, injections fit best within a broader plan: exercise‑based physical therapy and weight reduction have the strongest long‑term evidence, and an RCT shows PT outperforms a single steroid injection at one year. Alternatives and complements include topical NSAIDs, duloxetine for centralized pain, bracing, HA or PRP injections, and, for refractory severe disease, surgical referral. Shared decision‑making should weigh expected short‑term relief, structural risks with repetition, comorbidities, and patient goals.

Traditional Chinese Medicine (TCM) understands knee osteoarthritis as Bi syndrome—painful obstruction due to wind, cold, and damp that lodge in weakened tissues. The approach is two‑pronged: expel pathogenic factors (move qi and blood, warm channels) and strengthen the terrain (tonify Liver and Kidney to nourish sinews and bone). While corticosteroid injections are not part of TCM, an integrative strategy views them as a brief window to reduce acute obstruction so that restorative practices can begin. Acupuncture and electroacupuncture are central modalities, using local and distal points to modulate pain pathways, improve microcirculation, and reduce inflammation. Systematic reviews and RCTs show modest improvements in pain and function, with a favorable safety profile. Moxibustion or topical heat may be emphasized for cold‑damp patterns to ease stiffness. Movement therapies—Tai Chi and Qigong—align with joint preservation: gentle, mindful motion improves balance, neuromuscular control, and psychological resilience. A head‑to‑head trial of Tai Chi versus physical therapy found comparable benefits, highlighting mind‑body practice as a viable first‑line option for many. In Ayurveda, KOA (Sandhivata) is linked to Vata aggravation; treatments aim to calm Vata and nourish tissues through warm oil applications (snehana), gentle heat (swedana), and herbs that reduce inflammation and support joint comfort. Modern research on curcumin and Boswellia suggests anti‑inflammatory and analgesic effects consistent with traditional use. These can be considered adjuncts within an integrative plan. From this perspective, timing matters: use the short‑term analgesia from a steroid injection to initiate or intensify acupuncture, Tai Chi, and therapeutic exercise while pain is reduced, building capacity that endures after the injection’s effect wanes. Herbal strategies may help sustain comfort and decrease reliance on frequent injections, with attention to quality, interactions, and coordinated care. Eastern traditions emphasize individualized pattern diagnosis—recognizing that cold‑damp pain differs from deficiency patterns—and tailoring modalities accordingly. The shared goal with Western care is durable function and self‑management, achieved through coordinated, patient‑centered planning.